Anavex Life Sciences
AVXL
#9652
Rank
HK$0.88 B
Marketcap
HK$9.57
Share price
6.09%
Change (1 day)
-81.04%
Change (1 year)

EPS for Anavex Life Sciences (AVXL)

EPS in 2023 (TTM): -HK$5.17

According to Anavex Life Sciences 's latest financial reports the company's current EPS (TTM) is -HK$1.18. In 2022 the company made an earnings per share (EPS) of -HK$5.10 a decrease over its 2021 EPS that were of -HK$4.31.

EPS history for Anavex Life Sciences from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$5.171.48%
2022-HK$5.1018.18%
2021-HK$4.3122.22%
2020-HK$3.53-11.76%
2019-HK$4.0010.87%
2018-HK$3.6135.29%
2017-HK$2.67-10.53%
2016-HK$2.98-39.41%
2015-HK$4.92-45.94%
2014-HK$9.10180.17%
2013-HK$3.25-50.71%
2012-HK$6.59-22.22%
2011-HK$8.47-28.95%
2010-HK$11.9258.33%
2009-HK$7.53-11.11%
2008-HK$8.47107.69%
2007-HK$4.08
2006N/A-100%
2005-HK$0.12

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ligand Pharmaceuticals
LGND
HK$78.50-6,773.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
HK$4.08-446.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-HK$59.20 4,933.33%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-HK$11.29 860.00%๐Ÿ‡บ๐Ÿ‡ธ USA